Pages that link to "Q28184669"
Jump to navigation
Jump to search
The following pages link to 5‐HT6 receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex (Q28184669):
Displaying 36 items.
- Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats (Q28275114) (← links)
- 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease (Q28287100) (← links)
- 5-HT6 receptor antagonist reversal of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine. (Q30491992) (← links)
- Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission (Q30493133) (← links)
- Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data (Q33706897) (← links)
- Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex (Q34699454) (← links)
- 5-HT6/7 receptor antagonists facilitate dopamine release in the cochlea via a GABAergic disinhibitory mechanism. (Q34802345) (← links)
- Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task (Q34847404) (← links)
- Alzheimer's disease and age-related memory decline (preclinical) (Q35041190) (← links)
- N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties (Q36057491) (← links)
- The serotonin-6 receptor as a novel therapeutic target (Q37987116) (← links)
- Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease. (Q38627971) (← links)
- Potential serotonergic agents for the treatment of schizophrenia (Q38635792) (← links)
- Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain (Q41307502) (← links)
- Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action (Q41975639) (← links)
- Emerging role of sertindole in the management of schizophrenia (Q42427678) (← links)
- The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. (Q42597841) (← links)
- Effects of asenapine on prefrontal N‐methyl‐D‐aspartate receptor‐mediated transmission: Involvement of dopamine D1 receptors (Q42906958) (← links)
- A quantitative structure-activity relationship study on serotonin 5-HT6) receptor ligands: indolyl and piperidinyl sulphonamides. (Q43026448) (← links)
- 5-HT6 antagonism attenuates cue-induced relapse to cocaine seeking without affecting cocaine reinforcement (Q43082148) (← links)
- Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET. (Q45110152) (← links)
- Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved. (Q45977455) (← links)
- Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat. (Q46067102) (← links)
- Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms (Q46130784) (← links)
- Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040. (Q46397527) (← links)
- 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats (Q46450693) (← links)
- The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. (Q46547641) (← links)
- Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting (Q46597031) (← links)
- A comparison of multiple 5-HT receptors in two tasks measuring impulsivity (Q46735469) (← links)
- Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics. (Q46840298) (← links)
- Effects of the 5-HT6 receptor antagonists SB-399885 and RO-4368554 and of the 5-HT2A receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light–dark cycle (Q48343708) (← links)
- Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885. (Q50052167) (← links)
- Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics. (Q51976441) (← links)
- Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease. (Q55297754) (← links)
- Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences (Q89313952) (← links)
- Wikidata:Database reports/Constraint violations/P496 (← links | edit)